ConductScience.org, home
Study to Evaluate the Effect of Voxelotor Administered Orally to Patients With Sickle Cell Disease (GBT_HOPE)
API referenceFor AI assistants

Trial · NCT03036813

Adverse events321

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

121 to 140 of 321

Download this page as JSON
TypeEventOrgan systemGroupAffectedAt riskEvents
seriousMusculoskeletal chest painMusculoskeletal and connective tissue disordersVoxelotor 900 mg2922
seriousMusculoskeletal chest painMusculoskeletal and connective tissue disordersVoxelotor 1500 mg0880
seriousMusculoskeletal chest painMusculoskeletal and connective tissue disordersPlacebo1911
seriousHypersplenismBlood and lymphatic system disordersVoxelotor 900 mg0920
seriousHypersplenismBlood and lymphatic system disordersVoxelotor 1500 mg1881
seriousHypersplenismBlood and lymphatic system disordersPlacebo0910
seriousReticulocytopeniaBlood and lymphatic system disordersVoxelotor 900 mg0920
seriousReticulocytopeniaBlood and lymphatic system disordersVoxelotor 1500 mg1881
seriousReticulocytopeniaBlood and lymphatic system disordersPlacebo0910
seriousThrombocytopeniaBlood and lymphatic system disordersVoxelotor 900 mg1921
seriousThrombocytopeniaBlood and lymphatic system disordersVoxelotor 1500 mg0880
seriousThrombocytopeniaBlood and lymphatic system disordersPlacebo0910
seriousHaemolytic anaemiaBlood and lymphatic system disordersVoxelotor 900 mg0920
seriousHaemolytic anaemiaBlood and lymphatic system disordersVoxelotor 1500 mg0880
seriousHaemolytic anaemiaBlood and lymphatic system disordersPlacebo1911
seriousSplenic infarctionBlood and lymphatic system disordersVoxelotor 900 mg0920
seriousSplenic infarctionBlood and lymphatic system disordersVoxelotor 1500 mg0880
seriousSplenic infarctionBlood and lymphatic system disordersPlacebo1911
seriousThrombocytosisBlood and lymphatic system disordersVoxelotor 900 mg0920
seriousThrombocytosisBlood and lymphatic system disordersVoxelotor 1500 mg0880

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Previous pageNext page

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03036813/events?page=7

API referenceFor AI assistants